{
  "id": "56cf236f3975bb303a000002",
  "type": "factoid",
  "question": "Which calcium channels does ethosuximide target?",
  "ideal_answer": "Ethosuximide blocks the T-type calcium channels.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/10882031",
    "http://www.ncbi.nlm.nih.gov/pubmed/21112351",
    "http://www.ncbi.nlm.nih.gov/pubmed/21596106",
    "http://www.ncbi.nlm.nih.gov/pubmed/15078185",
    "http://www.ncbi.nlm.nih.gov/pubmed/17291698",
    "http://www.ncbi.nlm.nih.gov/pubmed/24933286",
    "http://www.ncbi.nlm.nih.gov/pubmed/11641441",
    "http://www.ncbi.nlm.nih.gov/pubmed/15638774",
    "http://www.ncbi.nlm.nih.gov/pubmed/26089446",
    "http://www.ncbi.nlm.nih.gov/pubmed/22924591",
    "http://www.ncbi.nlm.nih.gov/pubmed/19005061",
    "http://www.ncbi.nlm.nih.gov/pubmed/16171802",
    "http://www.ncbi.nlm.nih.gov/pubmed/21148095"
  ],
  "snippets": [
    {
      "text": "In the present study, we examined whether ethosuximide (ETX), a T-channel antagonist, could decrease the severity of ethanol withdrawal seizures by evaluating electrographical and behavioral correlates of seizure activity.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24933286",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In rats, intraplantar (i.pl.) administration of db-cAMP or PGE(2)  caused mechanical hyperalgesia, an effect suppressed by AKAPI, two distinct T-channel blockers, NNC 55-0396 and ethosuximide, or ZnCl(2) , known to inhibit Ca(v) 3.2 among T channels.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22924591",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Theta rhythms remained disrupted during a subsequent week of withdrawal but were restored with the T-type channel blocker ethosuximide.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21148095",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Given evidence that chemotherapy-induced neuropathic pain is blocked by ethosuximide, known to block T-type calcium channels, we examined if more selective T-type calcium channel blockers and also inhibitors of cystathionine-\u03b3-lyase (CSE), a major H\u2082S-forming enzyme in the peripheral tissue, are capable of reversing the neuropathic pain evoked by paclitaxel, an anti-cancer drug.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21596106",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The results demonstrate that both ethosuximide and the active metabolite of methsuximide, alpha-methyl-alpha-phenylsuccinimide (MPS), block human T-type channels in a state-dependent manner, with higher affinity for inactivated channels.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11641441",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "T-type channels display current at the end of long pulses (persistent current), and this current was especially sensitive to block (ethosuximide IC(50) = 0.6 mM).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11641441",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We tested the effects of several T-type calcium channel blockers, including zonisamide (ZNS), ethosuximide, lomerizine, amiloride, mibefradil, and NCC 55-0396, a mibefradil derivative, on tacrine-induced tremulous jaw movements (TJMs), an animal model of parkinsonian tremor.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21112351",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16171802",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Gallopamil and another T-type-channel blocker, ethosuximide, were included for comparison.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10882031",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The Ca(v)3.2 channel is sensitive to ethosuximide, amlodipine and amiloride.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15078185",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The purpose of the present study was to explore the analgesic effects of the low voltage-activated T-type Ca2+ channel blockers ethosuximide, trimethadione, and mibefradil in persistent and acute nociceptive tests.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16171802",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We tested the effects of several T-type calcium channel blockers, including zonisamide (ZNS), ethosuximide, lomerizine, amiloride, mibefradil, and NCC 55-0396, a mibefradil derivative, on tacrine-induced tremulous jaw movements (TJMs), an animal model of parkinsonian tremor. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21112351",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We focused on two T-type calcium blockers, trimethadione and ethosuximide, which are anti-epileptics approved by the Food and Drug Administration. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17291698",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Gallopamil and another T-type-channel blocker, ethosuximide, were included for comparison. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10882031",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020747",
    "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005013",
    "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015220",
    "http://www.biosemantics.org/jochem#4249275"
  ],
  "exact_answer": "T-type calcium channels"
}